Albert Jang
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Radiopharmaceutical Chemistry and Applications
Papers in
-
- Prostate Cancer Treatment and Research 12
- Renal cell carcinoma treatment 5
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Oliver A. Sartor (12 shared papers)Ayse Tuba Kendi (2 shared papers)Pedro Coelho Barata (20 shared papers)Geoffrey Bates Johnson (1 shared paper)Thorvardur Ragnar Halfdanarson (1 shared paper)Jin Wang (2 shared papers)Srikanth Kodali (1 shared paper)Jordan J. Karlitz (1 shared paper)
- Journals
- The Oncologist (5 papers)Clinical Genitourinary Cancer (4 papers)Cancers (3 papers)JCO Precision Oncology (2 papers)Nutrients (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Albert Jang
52 papers receiving 934 citations
Peers
Comparison fields: 5 of 60
- Oncology 158
- Radiology, Nuclear Medicine and Imaging 106
- Infectious Diseases 69
- Surgery 109
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Albert Jang
This map shows the geographic impact of Albert Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Jang more than expected).
Fields of papers citing papers by Albert Jang
This network shows the impact of papers produced by Albert Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Jang. The network helps show where Albert Jang may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2020 | 84 | |
| 3 | 2021 | 77 | |
| 4 | 2023 | 75 | |
| 5 | 2019 | 73 | |
| 6 | 2023 | 71 | |
| 7 | 2015 | 60 | |
| 8 | 2020 | 36 | |
| 9 | 2020 | 33 | |
| 10 | 2021 | 25 | |
| 11 | 2022 | 22 | |
| 12 | 2023 | 22 | |
| 13 | 2020 | 17 | |
| 14 | 2023 | 17 | |
| 15 | 2019 | 16 | |
| 16 | 2020 | 15 | |
| 17 | 2023 | 15 | |
| 18 | 2024 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 13 |
About Albert Jang
Albert Jang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Rheumatology and Genetics, having authored 56 papers that have together received 956 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Bladder and Urothelial Cancer Treatments (9 papers), Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Gut microbiota and health (3 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (158 citations), Radiology, Nuclear Medicine and Imaging (106 citations), Infectious Diseases (69 citations), Surgery (109 citations) and Pulmonary and Respiratory Medicine (76 citations). Albert Jang has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Oliver A. Sartor, Ayse Tuba Kendi, Pedro Coelho Barata, Geoffrey Bates Johnson, Thorvardur Ragnar Halfdanarson, Jin Wang, Srikanth Kodali, Jordan J. Karlitz, John Xie and Yuanhao Zu. Their work appears in journals such as The Oncologist, Clinical Genitourinary Cancer, Cancers, JCO Precision Oncology and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.